Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001140361-25-018349·Arcturus Therapeutics Holdings Inc.
Schedule 13G ownership disclosure
Arcturus Therapeutics Holdings Inc
Common Stock, par value $0.001 per share · CUSIP: 03969T109
Event date: 2025-03-31
- Filing-level shares
- 1,926,084
- Percent of class
- 7.1%
- Nikko Asset Management Americas, Inc.
Shares: 1,926,084 · Class: 7.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-25-018349
- Form type
- SCHEDULE 13G/A
- Filer
- Arcturus Therapeutics Holdings Inc.
- CIK
- CIK 1768224
- Filed
- May 12, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership